Vitality Watch

Dossier pubmed preclinical 16-jul-2026
Animal model, organoid, or cell-culture result — not yet human

Age-associated decline of Lamtor5 drives immunosenescence and systemic aging via cGAS-mediated paracrine inflammation.

Key claim: Age-associated decline of Lamtor5 drives macrophage immunosenescence and systemic aging by impairing ESCRT-mediated cGAS degradation, and macrophage-targeted cGAS blockade or senolytics alleviate aging phenotypes in mice.

Abstract

Despite emerging evidences showing the close link between immunosenescence and organismal aging, whether and how aged innate immune system drives systemic aging remains an enigma, and importantly, how primary senescence is initiated and regulated needs to be addressed. Herein we identified late endosomal/lysosomal adapter, MAPK and mTOR activator 5 (Lamtor5) as an age-dependent factor that controlled macrophage senescence and peripheral aging. Specifically, we demonstrated that Lamtor5 ablating macrophages displayed senescent signatures, metabolic defects, aging-related transcriptomic and epigenetic features, nicely concurring with macrophages from naturally aging mice. Importantly, delivery of senescent Lamtor5 ablating macrophages accelerated aging in young mice, while transplantation of young macrophages or senolytic elimination of senescent cells corrected the aging manifestation in myeloid Lamtor5 conditional knockout (CKO) mice. Mechanistically, Lamtor5 physically interacted with cGMP-AMP synthase (cGAS) and promoted its degradation in an ESCRT manner. Accordingly, application of macrophage-targeting cGAS small interfering RNA (siRNA) or a small peptide targeting the Lamtor5/cGAS interface profoundly alleviated aging-associated inflammation and tissue dysfunction in aged mice. Collectively, the findings shed the light on immunosenescence and its central role during organismal aging, thereby opening a new avenue for developing macrophage-based therapeutics to improve healthy aging.

Why this matters

Most cGAS–STING accounts of aging center on ligand supply — mtDNA leakage, cytoplasmic chromatin, retroelement RNA/DNA. This finding shifts attention to cGAS clearance: an age-dependent Ragulator component (Lamtor5) gates ESCRT-dependent lysosomal degradation of cGAS specifically in macrophages, making tissue macrophages a proposed proximal amplifier of inflammaging via paracrine signaling. It also sharpens the senolytics narrative by nominating a defined upstream node (macrophage cGAS) whose selective blockade phenocopies senescent-cell clearance in mice — but the entire chain remains preclinical and macrophage-restricted delivery in humans is unsolved.

Source

Link

Briefing card

Age-associated decline of Lamtor5 drives immunosenescence and systemic aging via cGAS-mediated paracrine inflammation.
Stage: preclinical · pubmed · 16-jul-2026

Age-associated decline of Lamtor5 drives macrophage immunosenescence and systemic aging by impairing ESCRT-mediated cGAS degradation, and macrophage-targeted cGAS blockade or senolytics alleviate aging phenotypes in mice.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1038/s41418-026-01823-5

build build 880 · 2bcef25 · 2026-11-18